For example, the detection of myomiR levels in the serum of DMD patients would certainly be easier to assess compared to the detection of dystrophin restoration checked on muscle specimens of patients treated with disease-modifying therapies. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.